Febrile Seizures: A Clinical Dilemma in the Emergency Department - JA0008057-0000-19-135-H01-P

Febrile Seizures: A Clinical Dilemma in the Emergency Department

by Shana Jiang, PharmD, BCPS
(4.3 / 9 ratings )

This course is credentialed for:
Pharmacy (0.50 Contact Hr)

Price: $11.00
CE-PRO Price: $5.50


Febrile seizure, the most commonly occurring seizure disorder of childhood, is characterized by fever (temperature >100.4 F or 38 C) in the absence of central nervous system infection, most prevalent in children ages 6 months to 5 years.  Evaluating clinicians must focus on identifying the source of the fever and seizure, including ruling out infectious etiologies, such as meningitis. Secondary prophylaxis with intermittent oral/rectal diazepam and continuous prophylaxis with oral phenobarbital or valproate have been shown to be effective for reducing risk of recurrence but not in occurrence of epilepsy. Vaccine-induced febrile seizure is rare, and healthcare professionals should educate parents about the rare risk of febrile seizures happening because of vaccination versus the benefits of vaccinating.


The goal of this continuing education program is to educate healthcare professionals, especially pharmacists and pharmacy technicians, to be aware of febrile seizure background, treatment options, their intended drug effects, adverse events, monitoring parameters, and education for parents so that they can be more involved with their child’s health.
  • Understand the etiology and pathophysiology of febrile seizures
  • Identify four risk factors linked to recurrent febrile seizures
  • Evaluate methods to diagnose and treat febrile seizures
  • Learn important caregiver counseling points that relate to long-term management

Approval Information
This course is intended for pharmacists
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
Type of Activity: Knowledge
Initial Release Date: 10/24/2018
This CE module provides information about an off-label use of a product for a purpose other than for which the FDA approved it.

Course Originally Released on: 11/20/2013
Date of Most Recent Review: 1/1/2019
Course Termination/Update Date: 12/31/2019

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.


For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Michele-Juanita R - Tampa, FL  ·  Mar 24, 2019
It was a good course
Was this review helpful?  0
Price: $11.00
CE-PRO Price: $5.50